OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sacubitril/valsartan inhibits obesity-associated diastolic dysfunction through suppression of ventricular-vascular stiffness
Annayya R. Aroor, Srinivas Mummidi, Juan Carlos López-Alvarenga, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 24
Annayya R. Aroor, Srinivas Mummidi, Juan Carlos López-Alvarenga, et al.
Cardiovascular Diabetology (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 24
Showing 24 citing articles:
miR-181c targets Parkin and SMAD7 in human cardiac fibroblasts: Validation of differential microRNA expression in patients with diabetes and heart failure with preserved ejection fraction
Stanislovas S. Jankauskas, Pasquale Mone, Roberta Avvisato, et al.
Mechanisms of Ageing and Development (2023) Vol. 212, pp. 111818-111818
Open Access | Times Cited: 30
Stanislovas S. Jankauskas, Pasquale Mone, Roberta Avvisato, et al.
Mechanisms of Ageing and Development (2023) Vol. 212, pp. 111818-111818
Open Access | Times Cited: 30
Exploring the Complex Relationship between Diabetes and Cardiovascular Complications: Understanding Diabetic Cardiomyopathy and Promising Therapies
Nilanjan Ghosh, Leena Chacko, Hiranmoy Bhattacharya, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1126-1126
Open Access | Times Cited: 29
Nilanjan Ghosh, Leena Chacko, Hiranmoy Bhattacharya, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1126-1126
Open Access | Times Cited: 29
Obesity: the perfect storm for heart failure
Maria Lembo, Teresa Strisciuglio, Celeste Fonderico, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 4, pp. 1841-1860
Open Access | Times Cited: 12
Maria Lembo, Teresa Strisciuglio, Celeste Fonderico, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 4, pp. 1841-1860
Open Access | Times Cited: 12
Neprilysin Inhibition in the Prevention of Anthracycline-Induced Cardiotoxicity
Aleksandra Sobiborowicz, Katarzyna Kamińska, Agnieszka Cudnoch‐Jędrzejewska
Cancers (2023) Vol. 15, Iss. 1, pp. 312-312
Open Access | Times Cited: 17
Aleksandra Sobiborowicz, Katarzyna Kamińska, Agnieszka Cudnoch‐Jędrzejewska
Cancers (2023) Vol. 15, Iss. 1, pp. 312-312
Open Access | Times Cited: 17
Molecular mechanisms of sacubitril/valsartan in cardiac remodeling
Nor Hidayah Mustafa, Juriyati Jalil, Satirah Zainalabidin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
Nor Hidayah Mustafa, Juriyati Jalil, Satirah Zainalabidin, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 25
Animal models of heart failure with preserved ejection fraction (HFpEF): from metabolic pathobiology to drug discovery
Si Gao, Xueping Liu, Tingting Li, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 1, pp. 23-35
Closed Access | Times Cited: 13
Si Gao, Xueping Liu, Tingting Li, et al.
Acta Pharmacologica Sinica (2023) Vol. 45, Iss. 1, pp. 23-35
Closed Access | Times Cited: 13
Angiotensin receptor–neprilysin inhibitors for hypertension—hemodynamic effects and relevance to hypertensive heart disease
Kazuomi Kario, Bryan Williams
Hypertension Research (2022) Vol. 45, Iss. 7, pp. 1097-1110
Closed Access | Times Cited: 22
Kazuomi Kario, Bryan Williams
Hypertension Research (2022) Vol. 45, Iss. 7, pp. 1097-1110
Closed Access | Times Cited: 22
Sacubitril/valsartan attenuates myocardial inflammation, hypertrophy, and fibrosis in rats with heart failure with preserved ejection fraction
Yujiao Shi, Chen Yang, Wen Qiao, et al.
European Journal of Pharmacology (2023) Vol. 961, pp. 176170-176170
Open Access | Times Cited: 11
Yujiao Shi, Chen Yang, Wen Qiao, et al.
European Journal of Pharmacology (2023) Vol. 961, pp. 176170-176170
Open Access | Times Cited: 11
Association Between Arterial Stiffness and Heart Failure With Preserved Ejection Fraction
Chen Chi, Yifan Liu, Yawei Xu, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 17
Chen Chi, Yifan Liu, Yawei Xu, et al.
Frontiers in Cardiovascular Medicine (2021) Vol. 8
Open Access | Times Cited: 17
Profiling the Biomechanical Responses to Workload on the Human Myocyte to Explore the Concept of Myocardial Fatigue and Reversibility: Rationale and Design of the POWER Heart Failure Study
Patrick Tran, Adam Linekar, Uday Dandekar, et al.
Journal of Cardiovascular Translational Research (2023) Vol. 17, Iss. 2, pp. 275-286
Open Access | Times Cited: 4
Patrick Tran, Adam Linekar, Uday Dandekar, et al.
Journal of Cardiovascular Translational Research (2023) Vol. 17, Iss. 2, pp. 275-286
Open Access | Times Cited: 4
Classification, Diagnosis, and Treatment of Obesity-Related Heart Diseases
Dan Chen, Juan Feng, HongYan He, et al.
Metabolic Syndrome and Related Disorders (2024) Vol. 22, Iss. 3, pp. 161-169
Closed Access | Times Cited: 1
Dan Chen, Juan Feng, HongYan He, et al.
Metabolic Syndrome and Related Disorders (2024) Vol. 22, Iss. 3, pp. 161-169
Closed Access | Times Cited: 1
Effects of sacubitril-valsartan on aging-related cardiac dysfunction
Marialucia Telesca, Antonella De Angelis, Maria Donniacuo, et al.
European Journal of Pharmacology (2024) Vol. 978, pp. 176794-176794
Open Access | Times Cited: 1
Marialucia Telesca, Antonella De Angelis, Maria Donniacuo, et al.
European Journal of Pharmacology (2024) Vol. 978, pp. 176794-176794
Open Access | Times Cited: 1
Sacubitril/Valsartan Combination Partially Improves Cardiac Systolic Function through β<sub>1</sub>-/β<sub>2</sub>-AR Responsiveness but Not Diastolic Function in a Rat Model of Type 2 Diabetes
Betül Rabia Erdoğan, Zeynep Elif Yeşilyurt, Irem Karaomerlioglu, et al.
(2024)
Open Access | Times Cited: 1
Betül Rabia Erdoğan, Zeynep Elif Yeşilyurt, Irem Karaomerlioglu, et al.
(2024)
Open Access | Times Cited: 1
Sacubitril/valsartan improves diastolic left ventricular stiffness with increased titin phosphorylation via cGMP-PKG activation in diabetic mice
Nozomi Furukawa, Hiroki Matsui, Hiroaki Sunaga, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Nozomi Furukawa, Hiroki Matsui, Hiroaki Sunaga, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Key Phenotypes of Heart Failure with Preserved Ejection Fraction
Kazuki Kagami, Tomonari Harada, Hideki Ishii, et al.
Cardiology Clinics (2022) Vol. 40, Iss. 4, pp. 415-429
Closed Access | Times Cited: 6
Kazuki Kagami, Tomonari Harada, Hideki Ishii, et al.
Cardiology Clinics (2022) Vol. 40, Iss. 4, pp. 415-429
Closed Access | Times Cited: 6
Angiotensin Receptor–Neprilysin Inhibition (Sacubitril/Valsartan) Reduces Structural Arterial Stiffness in Middle‐Aged Mice
Isabel N. Schellinger, Angelika Dannert, Annett Hoffmann, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 4
Open Access
Isabel N. Schellinger, Angelika Dannert, Annett Hoffmann, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 4
Open Access
Sacubitril/Valsartan Combination Partially Improves Cardiac Systolic, but Not Diastolic, Function through β-AR Responsiveness in a Rat Model of Type 2 Diabetes
Betül Rabia Erdoğan, Zeynep Elif Yeşilyurt, Irem Karaomerlioglu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10617-10617
Open Access
Betül Rabia Erdoğan, Zeynep Elif Yeşilyurt, Irem Karaomerlioglu, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10617-10617
Open Access
Cardiometabolic effects of sacubitril/valsartan in a rat model of heart failure with preserved ejection fraction
Sandra Moraña‐Fernández, Xocas Vázquez‐Abuín, Alana Aragón‐Herrera, et al.
Biochemical Pharmacology (2024), pp. 116571-116571
Closed Access
Sandra Moraña‐Fernández, Xocas Vázquez‐Abuín, Alana Aragón‐Herrera, et al.
Biochemical Pharmacology (2024), pp. 116571-116571
Closed Access
Reducing Cardiac Steatosis: Interventions to Improve Diastolic Function: A Narrative Review
Kiyan Heshmat‐Ghahdarijani, Roya Modaresi, Sobhan Pourmasjedi, et al.
Current Problems in Cardiology (2023) Vol. 48, Iss. 8, pp. 101739-101739
Closed Access | Times Cited: 1
Kiyan Heshmat‐Ghahdarijani, Roya Modaresi, Sobhan Pourmasjedi, et al.
Current Problems in Cardiology (2023) Vol. 48, Iss. 8, pp. 101739-101739
Closed Access | Times Cited: 1
Searching for Effective Treatments in HFpEF: Implications for Modeling the Disease in Rodents
Magdalena Jasińska-Stroschein
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1449-1449
Open Access | Times Cited: 1
Magdalena Jasińska-Stroschein
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1449-1449
Open Access | Times Cited: 1
Modern Approaches to Treatment of Chronic Heart Failure in Patients with Type 2 Diabetes Mellitus
Yu. G. Gorb, S. A. Serik, О. В. Ткаченко, et al.
Ukraïnsʹkij žurnal medicini bìologìï ta sportu (2022) Vol. 7, Iss. 1, pp. 14-31
Open Access | Times Cited: 1
Yu. G. Gorb, S. A. Serik, О. В. Ткаченко, et al.
Ukraïnsʹkij žurnal medicini bìologìï ta sportu (2022) Vol. 7, Iss. 1, pp. 14-31
Open Access | Times Cited: 1
Diabetic Heart Failure with Preserved Left Ventricular Ejection Fraction: Review of Current Pharmacotherapy
J Benko, Matej Samoš, Tomáš Bolek, et al.
Journal of Diabetes Research (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 1
J Benko, Matej Samoš, Tomáš Bolek, et al.
Journal of Diabetes Research (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 1
Sacubitril/valsartan cardioprotective effect against cisplatin-induced cardiotoxicity via modulation of VEGF/eNOS and TLR4/TNFα/IL6 signalling pathways
Marwa M. M. Refaie, Rehab Ahmed Rifaai, Asmaa M. A. Bayoumi, et al.
Journal of Pharmacy and Pharmacology (2023) Vol. 75, Iss. 9, pp. 1237-1248
Closed Access
Marwa M. M. Refaie, Rehab Ahmed Rifaai, Asmaa M. A. Bayoumi, et al.
Journal of Pharmacy and Pharmacology (2023) Vol. 75, Iss. 9, pp. 1237-1248
Closed Access
"<i>Primum non nocere</i> (First, do no harm)". Case report
D. A. Nefedova, R. P. Myasnikov, S. A. Beregovskaya
CARDIOVASCULAR THERAPY AND PREVENTION (2023) Vol. 22, Iss. 7S, pp. 3625-3625
Open Access
D. A. Nefedova, R. P. Myasnikov, S. A. Beregovskaya
CARDIOVASCULAR THERAPY AND PREVENTION (2023) Vol. 22, Iss. 7S, pp. 3625-3625
Open Access
